JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB180960

Anti-MRP1 antibody [EPR4658(2)] - C-terminal

Be the first to review this product! Submit a review

|

(12 Publications)

Rabbit Recombinant Monoclonal MRP1 antibody. C-terminal. Suitable for WB and reacts with Human samples. Cited in 12 publications.

View Alternative Names

MRP, MRP1, ABCC1, Multidrug resistance-associated protein 1, ATP-binding cassette sub-family C member 1, Glutathione-S-conjugate-translocating ATPase ABCC1, Leukotriene C(4) transporter, LTC4 transporter

3 Images
Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)
  • WB

Supplier Data

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)

Lanes 1 - 2 : Merged signal (red and green). Green - ab180960 observed at 170 kDa. Red - loading control, ab130007, observed at 130 kDa.

ab180960 was shown to specifically react with ABCC1 in wild-type A549 cells as signal was lost in ABCC1 knockout cell line ab261871 (knockout cell lysate ab261680). Wild-type and ABCC1 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% milk. ab180960 and ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/1000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (ab180960) at 1/1000 dilution

Lane 1:

Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

Western blot - Human ABCC1 (MRP1) knockout A549 cell lysate (<a href='/en-us/products/cell-lysates/human-abcc1-mrp1-knockout-a549-cell-lysate-ab261680'>ab261680</a>) at 20 µg

Secondary

Lanes 1 - 2:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Lanes 1 - 2:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution

Predicted band size: 171 kDa

Observed band size: 171 kDa,130 kDa

false

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)
  • WB

Lab

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)

Blocking and dilution buffer : 5% NFDM/TBST.

If there is no ideal result on boiled sample, we suggest not to boil sample before loading onto the gel.

All lanes:

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (ab180960) at 1/1000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate (boiled) at 20 µg

Lane 2:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 171 kDa

false

Exposure time: 20s

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)
  • WB

Supplier Data

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (AB180960)

All lanes:

Western blot - Anti-MRP1 antibody [EPR4658(2)] - C-terminal (ab180960) at 1/5000 dilution

All lanes:

A549 cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 171 kDa

false

  • Carrier free

    Anti-MRP1 antibody [EPR4658(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4658(2)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MRP1 also known as ABCC1 is a transporter protein with a mass of approximately 190 kDa. This protein belongs to the ATP-binding cassette (ABC) transporter family. MRP1 actively exports a variety of substrates from cells by hydrolyzing ATP to ADP and inorganic phosphate. You can find MRP1 expressed in many tissues including the lung testis and kidney. It helps in cellular detoxification by exporting organic anions and other conjugated metabolites.
Biological function summary

This protein functions as an important determinant of multidrug resistance in cancer treatment. MRP1 can form part of a larger protein complex that includes other transporters like MRP2. Through its activity MRP1 protects tissues from toxic substances by transporting them out of the cell. Its role in transporting glutathione-conjugated compounds highlights its importance in cellular defense mechanisms against oxidative stress and xenobiotics.

Pathways

MRP1 participates in the glutathione metabolism and the xenobiotic efflux pathways. Both pathways involve cellular detoxification and the accumulation of anomalies can cause harmful effects in the body. MRP1 works with proteins such as GSTP1 which conjugates toxic substances with glutathione preparing them for export by MRP1. This coordination ensures efficient detoxification and protection of cells from damage.

MRP1 has associations with several conditions particularly drug resistance in various cancers and chronic obstructive pulmonary disease (COPD). In cancer MRP1 overexpression often results in reduced treatment efficacy due to chemotherapy drugs being expelled from the cell helping to resist their cytotoxic effects. Research indicates a connection between MRP1 and P-glycoprotein (ABCB1) in cancer drug resistance pointing to a broader resistive mechanism in which multiple transporters are involved.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates export of organic anions and drugs from the cytoplasm (PubMed : 10064732, PubMed : 11114332, PubMed : 16230346, PubMed : 7961706, PubMed : 9281595). Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics (PubMed : 10064732, PubMed : 11114332, PubMed : 16230346, PubMed : 7961706, PubMed : 9281595). Confers resistance to anticancer drugs by decreasing accumulation of drug in cells, and by mediating ATP- and GSH-dependent drug export (PubMed : 9281595). Hydrolyzes ATP with low efficiency (PubMed : 16230346). Catalyzes the export of sphingosine 1-phosphate from mast cells independently of their degranulation (PubMed : 17050692). Participates in inflammatory response by allowing export of leukotriene C4 from leukotriene C4-synthesizing cells (By similarity). Mediates ATP-dependent, GSH-independent cyclic GMP-AMP (cGAMP) export (PubMed : 36070769). Thus, by limiting intracellular cGAMP concentrations negatively regulates the cGAS-STING pathway (PubMed : 36070769). Exports S-geranylgeranyl-glutathione (GGG) in lymphoid cells and stromal compartments of lymphoid organs. ABCC1 (via extracellular transport) with GGT5 (via GGG catabolism) establish GGG gradients within lymphoid tissues to position P2RY8-positive lymphocytes at germinal centers in lymphoid follicles and restrict their chemotactic transmigration from blood vessels to the bone marrow parenchyma (By similarity). Mediates basolateral export of GSH-conjugated R- and S-prostaglandin A2 diastereomers in polarized epithelial cells (PubMed : 9426231).
See full target information ABCC1

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Oral diseases 30:433-447 PubMed36453015

2022

Shikonin enhances chemosensitivity of oral cancer through β-catenin pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Xiang,Lujie Si,Ying Zheng,Huiming Wang

Frontiers in pharmacology 12:805499 PubMed35002739

2021

Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjuan Zeng,Shanshan Zheng,Yonghong Mao,Shisheng Wang,Yi Zhong,Wei Cao,Tao Su,Meng Gong,Jingqiu Cheng,Yong Zhang,Hao Yang

Molecular medicine (Cambridge, Mass.) 26:114 PubMed33228517

2020

Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.

Applications

Unspecified application

Species

Unspecified reactive species

Chong Wang,Lingling Li,Mengya Li,Weiqiong Wang,Yanfang Liu,Shujuan Wang

International journal of molecular sciences 21: PubMed33081264

2020

Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines.

Applications

Unspecified application

Species

Unspecified reactive species

Floren G Low,Kiran Shabir,James E Brown,Roslyn M Bill,Alice J Rothnie

Frontiers in oncology 9:1246 PubMed31921616

2019

Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5.

Applications

Unspecified application

Species

Unspecified reactive species

Siwei Li,Bo Zhao,Haiying Zhao,Cui Shang,Man Zhang,Xiaoxia Xiong,Jinjin Pu,Bohua Kuang,Guangrui Deng

OncoTargets and therapy 12:5751-5765 PubMed31410021

2019

Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Bili Wang,Can Shen,Yang Li,Ting Zhang,Hui Huang,Jun Ren,Zhengjun Hu,Jian Xu,Bin Xu

Journal of biosciences 44: PubMed31180057

2019

LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.

Applications

Unspecified application

Species

Unspecified reactive species

Ben-DI Mao,Ping Xu,Ping Xu,Yan Zhong,Wei-Wei Ding,Qing-Zhi Meng

Nutrition and cancer 71:1007-1018 PubMed31032633

2019

Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yongjun Li,Yukai Guo,Zhuang Feng,Raymond Bergan,Bo Li,Yongliang Qin,Lianmei Zhao,Zhenzhen Zhang,Min Shi

EBioMedicine 40:251-262 PubMed30738829

2019

Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Wang,Songbing He,Yuting Gu,Qiwei Wang,Xiao Chu,Min Jin,Liang Xu,Qiong Wu,Qianjun Zhou,Bei Wang,Yanyun Zhang,Hui Wang,Leizhen Zheng

Experimental and therapeutic medicine 15:4885-4889 PubMed29805510

2018

The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Guo,Zhili Cao,Huiqin Guo,Shanqing Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com